Plantarc Bio Ltd Asset Resilience Ratio
Plantarc Bio Ltd asset resilience ratio. Plantarc Bio Ltd (PLNT) has an Asset Resilience Ratio of 34.61% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read total liabilities of Plantarc Bio Ltd for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Plantarc Bio Ltd (2022–2023)
Asset resilience ratio of Plantarc Bio Ltd from 2022 to 2023. This chart shows how Plantarc Bio Ltd's Asset Resilience Ratio has changed over time. See Plantarc Bio Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Liquid Assets Composition Over Time
This chart breaks down Plantarc Bio Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Plantarc Bio Ltd assets under control.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ILA0.00 | 0% |
| Short-term Investments | ILA4.07 Million | 34.61% |
| Total Liquid Assets | ILA4.07 Million | 34.61% |
Asset Resilience Insights
- Very High Liquidity: Plantarc Bio Ltd maintains exceptional liquid asset reserves at 34.61% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Plantarc Bio Ltd Industry Peers by Asset Resilience Ratio
Compare Plantarc Bio Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN |
Biotechnology | 0.00% |
|
HLB Co. Ltd
KQ:028300 |
Biotechnology | 3.29% |
|
Tubize-Fin
BR:TUB |
Biotechnology | 2.50% |
|
Shanghai Medicilon Inc
SHG:688202 |
Biotechnology | 6.69% |
|
Blue Jet Healthcare Limited
NSE:BLUEJET |
Biotechnology | 13.81% |
|
Hangzhou Biotest Biotech Co Ltd
SHG:688767 |
Biotechnology | 0.56% |
|
Shouyao Holdings (Beijing) Co. Ltd. A
SHG:688197 |
Biotechnology | 79.76% |
|
Shenzhen Weiguang Biological Products Co Ltd
SHE:002880 |
Biotechnology | 5.52% |
Plantarc Bio Ltd Asset Resilience Ratio by Year (2022–2023)
Plantarc Bio Ltd asset resilience ratio by year from 2022 to 2023. The table below shows the annual Asset Resilience Ratio data for Plantarc Bio Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 63.07% | ILA8.32 Million ≈ $22.30K |
ILA13.19 Million ≈ $35.35K |
+10.24pp |
| 2022-12-31 | 52.83% | ILA8.05 Million ≈ $21.57K |
ILA15.23 Million ≈ $40.83K |
-- |
About Plantarc Bio Ltd
PlantArc Bio Ltd. operates as an Ag-Bio company for the crop protection and yield enhancement. The company develops and operates a Direct-In-Plant gene discovery platform. It focuses on yield improvement, drought resistance, and herbicide and insects tolerance. The company was incorporated in 2014 and is based in Ra'anana, Israel.